TABLE 1.

Baseline Characteristics

	FMT (n = 13)	Placebo (n = 13)	P
Male sex	7 (53.8%)	8 (61.5%)	0.691
Mean age, y ± SD	42.7 ± 10.2	45.5 ± 11.7	0.614
Median y from IPAA surgery	9.8 (1.6-21.9)	8.3 (3.0-26.6)	0.918
Antibiotic use at time of study enrollment			0.431
Continuous use	5	7
Repeated	8	6
Probiotics	5	6	0.691